Leveraging a High-Impact Publication and a Webinar to Drive Lead Generation

ALZpath

Leveraging a High-Impact Publication and a Webinar to Drive Lead Generation

Background

ALZpath develops timely and accessible diagnostics for Alzheimer’s Disease (AD). To date, they have the only commercially available test for phosphorylated tau 217 (pTau217), a reliable disease blood-biomarker that correlates with brain disease even before cognitive symptoms.

Campaign Objectives

The ALZpath pTau217 assay was featured in a publication in JAMA Neurology that reported positive results, further strengthening the possibility of accessible, less invasive, and accurate Alzheimer’s Disease diagnostics. To generate leads and increase awareness, ALZpath wanted to host a webinar to discuss their assay and the publication results.

Samba Approach

Samba Scientific set up the webinar infrastructure and developed a registration landing page tailored to capture the most relevant information from registrants. Additionally, we deployed a promotional campaign consisting of promotional emails and social media posts. Emails and posts were strategically crafted to engage the target audience and scheduled to maximize interactions. Finally, we crafted post-webinar social to drive on-demand views of the webinar recording.

Campaign Results

Samba’s promotional campaign generated 400+ registrants, with an attendance rate of 50%! Many relevant questions were discussed, and the webinar recording continues to generate on-demand views.